IMJUDO conc perf 300 mg/15ml vial 15 ml
7680687060028
CH-68706
L01FX20
07.16.1.
Reimbursement limitations:
IMJUDO_HCC
HCC
IMJUDO en association avec IMFINZI est remboursé pour le traitement des patients atteints de …
1 / 3
google
Details
- Product number
- 6870602
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- tremelimumabum 300 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, dinatrii edetas corresp. natrium 0.185 mg, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 15 ml.
Articles (1)
Imjudo 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.185 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 17897.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2025
Authorization holder
AstraZeneca AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 68706
- Drug name
- Imjudo, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FX20
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 13/09/2023
- Authorization expiration date
- 12/09/2028
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- IMJUDO conc perf 300 mg/15ml vial 15 ml
- Description (DE)
- IMJUDO Inf Konz 300 mg/15ml Vial 15 ml
- Market launch
- 13/09/2023
- Narcotic (BTM)
- No